The Role of Radiotherapy After Radical Prostatectomy in Patients with Prostate Cancer
- 432 Downloads
A non-negligible proportion of prostate cancer (PCa) patients undergoing radical prostatectomy (RP) harbors aggressive disease. These individuals are at higher risk of experiencing recurrence after surgery. Results from prospective, randomized trials support the efficacy of adjuvant radiotherapy (aRT) on cancer control in selected patients with adverse disease features at RP. However, only one of these randomized trials found a significant benefit of aRT on survival. Although such a level of evidence is not currently available for salvage RT, retrospective studies demonstrated that this approach leads to excellent outcomes if administered at the earliest sign of PSA recurrence. Prognostic models might help clinicians in identifying patients who would benefit the most from adjuvant and/or salvage RT. This individualized approach would allow sparing the risk of short- and long-term toxicity in a substantial proportion of patients. Nonetheless, results from randomized trials are still awaited to compare the efficacy of (early) salvage and aRT.
KeywordsProstate cancer Radical prostatectomy Salvage radiotherapy Multi-modal treatment Adjuvant radiotherapy Androgen deprivation therapy
Compliance with Ethics Guidelines
Conflict of Interest
Giorgio Gandaglia, Cesare Cozzarini, Alexandre Mottrie, Alberto Bossi, Nicola Fossati, Francesco Montorsi, and Alberto Briganti declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 5.Fossati N, Passoni NM, Moschini M, et al. Impact of stage migration and practice changes on high risk prostate cancer: results from patients treated with radical prostatectomy over the last two decades. BJU Int. 2015. doi: 10.1111/bju.13125.
- 15.••Bolla M, van Poppel H, Tombal B, et al. Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911). Lancet. 2012;380:2018–27. Randomized controlled trial showing that aRT reduces the risk of BCR in patients with pT3 or pT2R1 pN0 PCa.CrossRefPubMedGoogle Scholar
- 16.••Wiegel T, Bottke D, Steiner U, et al. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. J Clin Oncol. 2009;27:2924–30. Randomized controlled including pT3N0 patients with an undetactable PSA after RP showing that aRT improves BCR-free survival.CrossRefPubMedGoogle Scholar
- 17.••Thompson IM, Tangen CM, Paradelo J, et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. J Urol. 2009;181:956–62. Randomized controlled including pT3N0 patients demonstrating an advantage of aRT on survival as compared to initial observation.PubMedCentralCrossRefPubMedGoogle Scholar
- 22.•Briganti A, Wiegel T, Joniau S, et al. Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis. Eur Urol. 2012;62:472–87. Retrospective study showing that early salvage RT leads to comparable outcomes as compared to aRT in patients with pT3N0 PCa.CrossRefPubMedGoogle Scholar
- 24.Terakawa T, Miyake H, Kurahashi T, Furukawa J, Takenaka A, Fujisawa M. Improved sensitivity for detecting micrometastases in pelvic lymph nodes by real-time reverse transcriptase polymerase chain reaction (RT-PCR) compared with conventional RT-PCR in patients with clinically localized prostate cancer undergoing radical prostatectomy. BJU Int. 2009;103:1074–8.CrossRefPubMedGoogle Scholar
- 25.Moschini M, Sharma V, Zattoni F, et al. Natural history of clinical recurrence patterns of lymph node-positive prostate cancer after radical prostatectomy. Eur Urol. 2015. doi: 10.1016/j.eururo.2015.03.036.
- 26.Nini A, Gandaglia G, Fossati N, et al. Patterns of clinical recurrence of node-positive prostate cancer and impact on long-term survival. Eur Urol. 2015. 10.1016/j.eururo.2015.04.035.
- 31.Carter HE, Martin A, Schofield D, et al. A decision model to estimate the cost-effectiveness of intensity modulated radiation therapy (IMRT) compared to three dimensional conformal radiation therapy (3DCRT) in patients receiving radiotherapy to the prostate bed. Radiother Oncol. 2014;112:187–93.CrossRefPubMedGoogle Scholar
- 35.Sineshaw HM, Gray PJ, Efstathiou JA, Jemal A. Declining use of radiotherapy for adverse features after radical prostatectomy: results from the National Cancer Data Base. Eur Urol. 2015. doi: 10.1016/j.eururo.2015.04.003.
- 38.Maurice MJ, Zhu H, Abouassaly R. Low utilization of immediate and delayed postoperative radiation for prostate cancer with adverse pathologic features. J Urol. 2015;194:972–6.Google Scholar
- 40.Daly T, Hickey BE, Lehman M, Francis DP, See AM. Adjuvant radiotherapy following radical prostatectomy for prostate cancer. Cochrane Database Syst Rev. 2011:CD007234Google Scholar
- 45.•Abdollah F, Suardi N, Cozzarini C, et al. Selecting the optimal candidate for adjuvant radiotherapy after radical prostatectomy for prostate cancer: a long-term survival analysis. Eur Urol. 2013;63:998–1008. Retrospective analysis showing that aRT might improve cancer-specific survival only in selected patients with more aggressive disease characteristics.CrossRefPubMedGoogle Scholar
- 47.Abdollah F, Karnes RJ, Gandaglia G, Fossati N, Montorsi F, Briganti A. Reply to C.G. Rusthoven et al. J Clin Oncol. 2015;33:1989.Google Scholar
- 49.•Abdollah F, Karnes RJ, Suardi N, et al. Impact of adjuvant radiotherapy on survival of patients with node-positive prostate cancer. J Clin Oncol. 2014;32:3939–47. Multi-institutional study demonstrating a positive impact of aRT on survival in selected patients with node-positive PCa.CrossRefPubMedGoogle Scholar
- 51.Rusthoven CG, Carlson JA, Kavanagh BD. External validation of the benefit of adjuvant radiotherapy for pathologic N1M0 prostate cancer. J Clin Oncol. 2015;33:1987–8.Google Scholar
- 52.•Briganti A, Karnes RJ, Joniau S, et al. Prediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomy. Eur Urol. 2014;66:479–86. Novel nomogram predicting the risk of recurrence in patients treated with early salvage RT.CrossRefPubMedGoogle Scholar
- 72.Briganti A, Joniau S, Gandaglia G, et al. Patterns and predictors of early biochemical recurrence after radical prostatectomy and adjuvant radiation therapy in men with pT3N0 prostate cancer: implications for multimodal therapies. Int J Radiat Oncol Biol Phys. 2013;87:960–7.CrossRefPubMedGoogle Scholar
- 75.Jackson WC, Schipper MJ, Johnson SB, et al. Duration of androgen deprivation therapy influences outcomes for patients receiving radiation therapy following radical prostatectomy. Eur Urol. 2015. doi: 10.1016/j.eururo.2015.05.009.